Keith Harshman received a PhD in Biochemistry from the California Institute of Technology in 1990. Following post-doctoral fellowships at the University of Zurich and the Sloan-Kettering Cancer Center, in 1993 he joined Myriad Genetics where he worked first as a Senior Scientist and later as the Director of Central Nervous System Disease Research.
In 1997 he moved to the Spanish National Biotechnology Center as the Head of the Functional Genomics Unit. In 2003 he joined the Center for Integrative Genomics at the University of Lausanne where he served as Coordinator of the Genomic Technologies Facility. He moved to the Health 2030 Genome Center in December of 2017.